论文部分内容阅读
目的:探讨孕早期孕妇促甲状腺激素检测应用价值。方法:随机选择2015年1月1日至2016年12月31日期间在我院接受早期促甲状腺激素检测的53例健康孕妇作为对照组研究对象,并随机选择同时期在我院接受早期促甲状腺激素检测的53例21-三体综合征孕妇作为观察组研究对象,比较两组产妇的检测结果,探讨孕早期孕妇促甲状腺激素检测应用价值。结果:观察组孕妇的血清TSH显著低于对照组(P<0.05);观察组孕妇的FT3、FT4均显著高于对照组(P<0.05);观察组孕妇游离β-人绒毛膜促性腺激素水平显著高于对照组(P<0.05)。结论:对孕早期孕妇实施促甲状腺激素检测可以作为21-三体综合征重要指标,提高21-三体综合征的检出率,进一步筛查染色体非整倍体胎儿。
Objective: To investigate the value of thyrotropin testing in pregnant women in early pregnancy. METHODS: Fifty-three healthy pregnant women undergoing early thyroid-stimulating hormone test in our hospital from January 1, 2015 to December 31, 2016 were selected randomly as the control group and were randomly selected to receive thyrotropin Hormone test of 53 cases of trisomy 21 pregnant women as the observation group, compared the test results of the two groups of maternal to explore pregnant women in early pregnancy thyrotropin detection value. Results: The levels of serum TSH in the observation group were significantly lower than those in the control group (P <0.05). FT3 and FT4 in the observation group were significantly higher than those in the control group (P <0.05). The free β-human chorionic gonadotropin The level was significantly higher than the control group (P <0.05). Conclusion: The detection of thyrotropin in pregnant women during the first trimester can be used as an important index in 21-trisomy syndrome to improve the detection rate of 21-trisomy syndrome and further screen the chromosome aneuploid fetus.